ATOSSA THERAPEUTICS, INC. — All Filings
620 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEL AM
EFFECT
FWP
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-012868 | Feb 4, 2025 | Jan 30, 2025 |
| 8-K | 8-K | 0000950170-24-134779 | Dec 10, 2024 | — |
| 424B5 | 424B5 | 0000950170-24-128656 | Nov 19, 2024 | — |
| 8-K | 8-K | 0000950170-24-128686 | Nov 19, 2024 | — |
| 8-K | 8-K | 0000950170-24-124655 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-124668 | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0000932471-24-000894 | Nov 12, 2024 | — |
| SC 13G | — | 0002012383-24-003546 | Nov 8, 2024 | — |
| SC 13G/A | — | 0000932471-24-000361 | Nov 4, 2024 | — |
| 8-K | 8-K | 0000950170-24-120268 | Nov 4, 2024 | — |
| SC 13G | — | 0002012383-24-001301 | Oct 22, 2024 | — |
| 8-K | 8-K | 0000950170-24-095097 | Aug 12, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-095102 | Aug 12, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0000950170-24-080497 | Jul 2, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079562 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079565 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079558 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079560 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079557 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079561 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079559 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | 4 | 0000950170-24-079563 | Jul 1, 2024 | Jun 27, 2024 |
| DEF 14A | DEF 14A | 0000950170-24-063763 | May 23, 2024 | — |
| EFFECT | — | 9999999995-24-001640 | May 23, 2024 | — |
| CORRESP | — | 0000950170-24-062968 | May 21, 2024 | — |
| UPLOAD | — | 0000000000-24-005860 | May 21, 2024 | — |
| DEL AM | DEL AM | 0001193125-24-138327 | May 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-058242 | May 13, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-058244 | May 13, 2024 | Mar 31, 2024 |
| S-3 | S-3 | 0000950170-24-058625 | May 13, 2024 | — |
| PRE 14A | PRE 14A | 0000950170-24-057478 | May 10, 2024 | — |
| ARS | ARS | 0000950170-24-057481 | May 10, 2024 | Dec 31, 2023 |
| 4 | 4 | 0000950170-24-043690 | Apr 11, 2024 | Apr 10, 2024 |
| 8-K/A | 8-K/A | 0000950170-24-039634 | Apr 2, 2024 | Apr 1, 2024 |
| 8-K | 8-K | 0000950170-24-039286 | Apr 1, 2024 | — |
| 10-K | 10-K | 0000950170-24-039306 | Apr 1, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0000950170-24-032535 | Mar 18, 2024 | Mar 15, 2024 |
| 3 | 3 | 0000950170-24-031813 | Mar 14, 2024 | Mar 9, 2024 |
| 4 | 4 | 0000950170-24-031815 | Mar 14, 2024 | Mar 9, 2024 |
| 8-K | 8-K | 0000950170-24-029671 | Mar 12, 2024 | Mar 9, 2024 |
| 4 | FORM 4 | 0001437749-23-032461 | Nov 17, 2023 | Nov 15, 2023 |
| 4 | FORM 4 | 0001437749-23-032166 | Nov 15, 2023 | — |
| 3 | FORM 3 | 0001437749-23-032174 | Nov 15, 2023 | Nov 8, 2023 |
| 4/A | FORM 4/A | 0001437749-23-032191 | Nov 15, 2023 | — |
| 8-K | FORM 8-K | 0001437749-23-031420 | Nov 13, 2023 | — |
| 10-Q | FORM 10-Q | 0001437749-23-031424 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | FORM 8-K | 0001437749-23-031085 | Nov 9, 2023 | — |
| 3 | FORM 3 | 0001437749-23-028277 | Oct 16, 2023 | Oct 6, 2023 |
| 8-K | FORM 8-K | 0001437749-23-027849 | Oct 6, 2023 | Oct 2, 2023 |
| 8-K | FORM 8-K | 0001437749-23-027048 | Sep 28, 2023 | Sep 26, 2023 |